Happy Holidays!

During the Holiday Season, more than ever, our thoughts turn gratefully to those who have made our progress possible.

And in this spirit we say, simply but sincerely, Thank You and Best Wishes for the Holiday Season and a Happy New Year!

Susan Thomas and Antonino Salon

Happy Thanksgiving from Susan

 

Wishing everyone a very Happy Thanksgiving! I love this holiday! Always filled with family, good stories, good food and very good times. I am most grateful to Antonino Salon and to Anthony Marsalese and Jeff Davison for this unique opportunity. I appreciate being able to continue my practice of seeing clients with hair loss needs. I am grateful for Deborah Sullivan, my assistant, and the entire Antonino Salon staff for their steadfast support of serving others in need. This year has been very exciting, as we have met so many wonderful clients and their family and friends. We have provided our clients with state of the art products and, most importantly, in my opinion, introduced them to the amazing talent of all the cosmetologists at the salon -- whose talent in all ways is unsurpassed. Their work on all wigs and hairpieces reflects many years of cutting, styling and fitting pieces to make them look the most natural in the market. The custom coloring done on human hair wigs reflects the talent, dedication and genius of all of them in producing hair color envied by all. For all of this, I am grateful, and for the continued blessing to meet so many, to connect, to serve, and to celebrate the success in making someone feel and look like themselves again. For that, I’m grateful!

Stay tuned to 2025…more exciting news to come for Susan At Antonino Salon! Happy Thanksgiving!

Welcome!!

 

Custom Color of the best human hair wig created for a very special person

Welcome to Susan at Antonino Salon!

At Susan at Antonino Salon, we believe in the transformative power of personalized beauty and care. Nestled in the heart of Birmingham, Michigan, our salon is more than just a place for beauty services—it’s a haven for those seeking comfort, confidence, and a renewed sense of self.

As a dedicated nurse, Susan brings a compassionate touch to her work, specializing in helping cancer patients and women with hair loss needs. She offers customized wig fittings and styling, ensuring each client feels beautiful and confident in their unique look.

Our range of services, from trendy haircuts and vibrant coloring to luxurious treatments, is designed to cater to all your beauty needs. But more than that, we pride ourselves on creating a warm, welcoming environment where you can relax and leave feeling more empowered than ever.

Join us on this beautiful journey. Whether you’re looking for a fresh new style or support through hair loss, we’re here for you. Welcome to Susan at Antonino Salon—where beauty and care go hand in hand.

 

Welcome to Susan At Antonino Salon-where luxury meets personalization with our exclusive collection of wigs. Step into a world of glamour and confidence as we can provide you with a custom wig detailed just for you.

At Antonino Salon and Spa, we understand the importance of privacy and individuality. That’s why we offer a private room for all wig appointments, ensuring a personalized experience tailored just for you.

Whether you’re looking for a natural look that compliments your style or a bold statement piece that expresses your personality, our custom cut and colored wigs are designed to make you feel fabulous inside and out.

Schedule your appointment today and discover a whole new world of beauty and elegance. 248-544-4287

Be sure to visit us to find out why we’ve been named best salon several years in a row by Hour Detroit.

Antonino Salon where there are “no bad hair days, ever.”

191 Townsend (across from the Townsend Hotel) in downtown Birmingham.

 This cute baseball cap with attached hair is perfect alternative to wearing a wig for that spur of the moment errand and other appointments. Available in multiple colors and lengths. Call for a quick appointment to visit our hair and accessories. 

Susans @ Antonino Salon

248-544-4287

191 Townsend St, Birmingham, MI 48009

IN AN INSTANT LIFE CAN CHANGE – DIAGNOSIS CANCER, CHEMOTHERAPY TREATMENT AND POSSIBLE HAIRLOSS

 

IN AN INSTANT LIFE CAN CHANGE – DIAGNOSIS CANCER, CHEMOTHERAPY TREATMENT AND POSSIBLE HAIRLOSS

FIRST STEP TO CALL SUSAN TO DISCUSS YOUR DIAGNOSIS AND SIDE EFFECTS

 

It wasn’t supposed to be me. I have had friends with cancer and silently glad it wasn’t me. But now reality strikes and I’m scared and need to talk with someone who has been there to help me decide what to do.

 

Susan is a Breast Cancer Survivor and Oncology Nurse Clinician. She has helped more than 13,000 women with wig solutions to help them through this difficult life experience. Susan and her staff will discuss your specific needs including hair loss timing, wig style and composition of our unique Custom Tailored Wigs constructed of Human Hair, Human Hair Synthetic Blend, or Synthetic, We will also review how to keep your wig healthy wig care instructions.

 

We are here to help you during the loss of your hair whether from chemotherapy, alopecia or other. Depending upon your chemotherapy drug and cycle will determine how long you will be experiencing hair loss. That will help you decide what is right for you.

CALL 248-544-4287 FREE consultation to explore wig solutions right for you. We look forward to your visit. Susan's @ Antonino Salon, Birmingham, MI is by appointment only on Monday and Tuesday from 10:00 AM - 4:00 PM.

FDA expedites approval of two new breast cancer treatments

By Rich Haridy

April 22, 2020

• Facebook
• Twitter
• Flipboard
• LinkedIn

The approval of two new treatments for breast cancer were expedited by the FDA to help high-risk populations during the coronavirus pandemic

karelnoppe/Depositphotos

VIEW 1 IMAGES

The U.S. Food and Drug Administration (FDA) has approved two new kinds of breast cancer treatments, one targeting HER2-positive cancers and a second for metastatic triple-negative breast cancer. The FDA notes approval for both treatments was expedited due to the novel coronavirus pandemic.

“As part of FDA’s ongoing and aggressive commitment to address the novel coronavirus pandemic, we continue to keep a strong focus on patients with cancer who constitute a vulnerable population at risk of contracting the disease,” says Richard Pazdur, director of the FDA’s Oncology Center for Excellence. “At this critical time, we continue to expedite oncology product development.”

On April 17 the FDA approved a treatment using a new drug called Tukysa (tucatinib). The approval is for Tukysa to be administered in combination with chemotherapy for patients suffering metastatic HER2-positive breast cancer.

The approval is not for Tukysa as a first-line therapy. Instead, patients must have received at least one prior anti-HER2 treatment before commencing Tukysa.

The approval was based on recently published Phase 3 clinical trial data showing positive results from the novel combination treatment. In particular, the treatment offers hope to those patients with brain metastases, an aggressive form of the disease with very low survival rates.

“Tukysa was approved four months prior to the FDA goal date, providing an example of this commitment and showing how our regular work in reviewing treatments for patients with cancer is moving forward without delay,” says Pazdur.

On April 22 the FDA granted accelerated approval to Trodelvy (sacituzumab govitecan-hziy). This therapy is targeted at patients with a particularly aggressive form of breast cancer known as triple-negative breast cancer.

Trodelvy comes with a relatively severe set of potential side effects, so the FDA approval only allows the therapy to be administered to patients following the failure of at least two other available therapies.

The Trodelvy application was also only granted under the provision of what is called "accelerated approval." This means further clinical trials or clinical data will be necessary before a full approval, however, the drug may be administered widely based on the criteria it is, “reasonably likely to predict a clinical benefit to patients” suffering from serious conditions with unmet medical needs.

“Chemotherapy has been the mainstay of treatment for triple-negative breast cancer,” says Pazdur. “The approval of Trodelvy today represents a new targeted therapy for patients living with this aggressive malignancy.”

As with the Tukysa case, Trodelvy’s approval was expedited due the FDA’s commitment in bringing oncology treatments more rapidly to market during the coronavirus pandemic.

https://newatlas.com/medical/breast-cancer-therapy-fda-tukysa-trodelvy-her2-triple-negative/?utm_source=New+Atlas+Subscribers&utm_campaign=a4c657c246-EMAIL_CAMPAIGN_2020_04_23_01_47&utm_medium=email&utm_term=0_65b67362bd-a4c657c246-90055698